The co-existence of high prevalence of vitamin D inadequacy among Canadians and high prevalence of systematic autoimmune rheumatic diseases (SARDs) raise the question on relationship between the two situations. Objective: To determine vitamin D status in known cases of common SARDs and compare to those with non-autoimmune diseases; further, to evaluate the impact of vitamin D on disease activity in rheumatoid arthritis (RA) cases. Methods: In a retrospective case-control study design, we evaluated 116 patients in a community clinic classified in two groups, Control group: patients with non-rheumatic disease ( n = 56), and Case group: those with rheumatic diseases ( n = 60). We compared plasma vitamin D status (25(OH)D), indicators of disease activity and other potential confounders. Further, we determined factors associated with disease activity in？RA cases. Results: The plasma 25(OH)D was significantly lower in Case group？(64.8？±？29.8) compared to Control group (86.8 ± 37.7). High number of SARDs outpatients 56%) had considerably low plasma 25(OH)D concentration. RA cases with low plasma 25(OH)D had over five times higher risk of disease activity (OR = 5.15 95% CI？1.16, 22.9; p = 0.031). Conclusion: Inadequate vitamin D status in SARDs cases, along with considerably strong association with disease activity in RA cases, indicate the need for proper evaluation of vitamin D status in this clinical population. Moreover, appropriate training should be given to the patients to ensure the intake of the recommended amount of vitamin D per day through diet or supplement.
References
[1]
Bernatsky, S.; Lix, L.; Hanly, G.J.; Hudson, M.; Badley, E.; Peschken, C.; Pineau, C.A.; Clarke, A.E.; Fortin, R.; Smith, M.; et al. Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol. Int. 2011, 31, 549–554, doi:10.1007/s00296-010-1591-2.
[2]
The Impact of Arthritis in Canada: Today and over the Next 30 Years. Available online: http://www.arthritisnetwork.ca/downloads/20111022_Impact_of_arthritis.pdf (accessed on 12 November 2012).
[3]
Cutolo, M.; Straub, R.H. Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res. Ther. 2009, 11, 218, doi:10.1186/ar2630.
[4]
Whiting, S.J.; Langlois, K.A.; Vatanparast, H.; Greene-Finestone, L.S. The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: An examination in children and adults with and without supplement use. Am. J. Clin. Nutr. 2011, 94, 128–135, doi:10.3945/ajcn.111.013268.
[5]
Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Available online: http://www.iom.edu/~/media/Files/Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20Report%20Brief.pdf (accessed on 26 September 2012).
[6]
Holick, M.F. Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinology 2012, 4, 183–190, doi:10.4161/derm.20015.
[7]
Cutolo, M.; Pizzorni, C.; Sulli, A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun. Rev. 2011, 11, 84–87, doi:10.1016/j.autrev.2011.08.003.
[8]
Kriegel, M.A.; Manson, J.E.; Costenbader, K.H. Does vitamin D affect risk of developing autoimmune disease? A systematic review. Semin. Arthritis Rheum. 2011, 40, 512–531, doi:10.1016/j.semarthrit.2010.07.009.
[9]
Song, G.G.; Bae, S.C.; Lee, Y.H. Association between vitamin D intake and the risk of rheumatoid arthritis: A meta-analysis. Clin. Rheumatol. 2012, 31, 1733–1739, doi:10.1007/s10067-012-2080-7.
[10]
Webb, A.R.; Kline, L.; Holick, M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab. 1988, 67, 373–378, doi:10.1210/jcem-67-2-373.
[11]
The DAS28 Score. National Rheumatoid Arthritis Society. Available online: http://www.nras.org.uk/about_rheumatoid_arthritis/established_disease/managing_well/the_das28_score.aspx (accessed on 11 September 2011).
[12]
Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911–1930, doi:10.1210/jc.2011-0385.
[13]
Cutolo, M.; Otsa, K.; Laas, K.; Yprus, M.; Lehtme, R.; Secchi, M.E.; Sulli, A.; Paolino, S.; Seriolo, B. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern vs. Southern Europe. Clin. Exp. Rheumatol. 2006, 24, 702–704.
[14]
Merlino, L.A.; Curtis, J.; Mikuls, T.R.; Cerhan, J.R.; Criswell, L.A.; Saag, K.G. Iowa Women’s Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women’s Health Study. Arthritis Rheum. 2004, 50, 72–77, doi:10.1002/art.11434.
[15]
Garcia-Lozano, J.R.; Gonzalez-Escribano, M.; Valenzuela, A.; Garcia, A.; Nú？ez-Roldán, A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur. J. Immunogenet. 2001, 28, 89–93, doi:10.1046/j.1365-2370.2001.00233.x.
[16]
Kr？ger, H.; Penttil？, I.M.; Alhava, E.M. Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand. J. Rheumatol. 1993, 22, 172–177, doi:10.3109/03009749309099266.
[17]
Oelzner, P.; Müller, A.; Deschner, F.; Hüller, M.; Abendroth, K.; Hein, G.; Stein, G. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif. Tissue Int. 1998, 62, 193–198, doi:10.1007/s002239900416.
[18]
Osteoporosis Canada. Available online: http://www.osteoporosis.ca/index.php/ci_id/5536/la_id/1.htm (accessed on 15 September 2012).
[19]
Sainaghi, P.P.; Bellan, M.; Carda, S.; Cerutti, C.; Sola, D.; Nerviani, A.; Molinari, R.; Cisari, C.; Avanzi, G.C. Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases. Rheumatol. Int. 2012, 32, 3365–3372, doi:10.1007/s00296-011-2170-x.
[20]
Vatanparast, H.; Calvo, M.S.; Green, T.J.; Whiting, S.J. Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate. J. Steroid Biochem. Mol. Biol. 2010, 121, 301–303, doi:10.1016/j.jsbmb.2010.03.079.
[21]
Sainaghi, P.P.; Bellan, M.; Nerviani, A.; Sola, D.; Molinari, R.; Cerutti, C.; Pirisi, M. Superiority of a high loading dose of cholecalciferol to correct hypovitaminosis D in patients with inflammatory/autoimmune rheumatic diseases. J. Rheumatol. 2013, 40, 166–172, doi:10.3899/jrheum.120536.
[22]
Sanders, K.M.; Stuart, A.L.; Williamson, E.J.; Simpson, J.A.; Kotowicz, M.A.; Young, D.; Nicholson, G.C. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 2010, 303, 1815–1822, doi:10.1001/jama.2010.594.
[23]
Lee, Y.H.; Bae, S.C.; Choi, S.J.; Ji, J.D.; Song, G.G. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: A meta-analysis. Mol. Biol. Rep. 2011, 38, 3643–3651, doi:10.1007/s11033-010-0477-4.
